Mary Ann Gray's Net Worth
Estimate Recalculated May 7, 2026 03:13PM EST
Who is Mary Ann Gray
Mary Ann Gray has an estimated net worth of $2.92 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, Keros Therapeutics, Inc., Sarepta Therapeutics, Inc., RAPT Therapeutics, Inc., ACADIA PHARMACEUTICALS INC, GALENA BIOPHARMA, INC., BioAtla, Inc., Seneca Biopharma, Inc., JUNIPER PHARMACEUTICALS INC, Compass Therapeutics, Inc., DYAX CORP, SENOMYX INC, TELIK INC, and GTC BIOTHERAPEUTICS INC.
SEC CIK
Mary Ann Gray's CIK is 0001261974
Past Insider Trading and Trends
2016 was Mary Ann Gray's most active year for acquiring shares with 17 total transactions. Mary Ann Gray's most active month to acquire stocks was the month of May. 2016 was Mary Ann Gray's most active year for disposing of shares, totalling 14 transactions. Mary Ann Gray's most active month to dispose stocks was the month of December. 2016 saw Mary Ann Gray paying a total of $1,833,343.01 for 699,250 shares, this is the most they've acquired in one year. In 2014 Mary Ann Gray cashed out on 24,500 shares for a total of $388,815.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
